Member Info for Brainer

For those who doesn’t know what okyo all about as RNS are not shown here:

It’s not AIM stock, it’s admitted in to the MAIN MARKET since 17th July,

Cheremin project

INTELLECTUAL PROPERTY

#1

They have the license for composition of matter and methodology for treating, inter alia, ocular inflammation, dry eye disease and ocular neuropathic pain with Chimeric

BAM-8

INTELLECTUAL PROPERTY

#2

‘Company acquired the benefit of a licence from Tufts of the right to exploit all of the intellectual property relating to the development of the endogenous peptide BAM-8 (“BAM-8”)’

It’s doing same pattern as Thursday, gradually rising 40% then jump to 150%

Spread gradually getting tighter as it settles in the main market

I used to use Barclays, you need to call them to buy stock newly entered to main market

If it’s Barclays then you have to call them, I recongise re-admissions or new listed late, as okyo re-admitted to Main Market, they might not let you buy online

Rest held by institutions and big players who lead this into main market from AIM

Institutions holds 67.13% :- Panetta Partners 47.95% + regent marchentile 6.24% + James Mellon 6.09%+ rosey mining 6.85% = 67.13%

Share held in nominees account: Beaufort Nominees 22% + PLINIAN CAPITAL LIMITED 8% = 30%

Held by institutions and nominees: 67.13% + 30% = 97.13%, so free float only 2.87%!

Do your own research

For those who doesn’t know what okyo all about as RNS are not shown here:

It’s not AIM stock, it’s admitted in to the MAIN MARKET since 17th July,

Cheremin project

INTELLECTUAL PROPERTY

#1

They have the license for composition of matter and methodology for treating, inter alia, ocular inflammation, dry eye disease and ocular neuropathic pain with Chimeric

BAM-8

INTELLECTUAL PROPERTY

#2

‘Company acquired the benefit of a licence from Tufts of the right to exploit all of the intellectual property relating to the development of the endogenous peptide BAM-8 (“BAM-8”)’

It’s about to explode any time, 3 mms on bid and one one ask at 5p, same pattern as Thursday, gradually rise then explode!

See you later

It’s up 2.94%, sell 4p and I think nt to buy 4.75p

For people with no idea lol!

http://okyopharma.com

Lol

And big boys on board!

Institutions holds 67.13% :- Panetta Partners 47.95% + regent marchentile 6.24% + James Mellon 6.09%+ rosey mining 6.85% = 67.13%

Share held in nominees account: Beaufort Nominees 22% + PLINIAN CAPITAL LIMITED 8% = 30%

Held by institutions and nominees: 67.13% + 30% = 97.13%, so free float only 2.87%!

Do your own research

First lesson 8am to 10am, so after 10

Work at 8am, so cant watch really

Buy when others fear and sell when others greedy!

Company acquired the benefit of a licence from Tufts of the right to exploit all of the intellectual property relating to the development of the endogenous peptide BAM-8 (“BAM-8”)’

patent WO2017014605 being claims in composition of matter and methodology for treating, inter alia, ocular inflammation, dry eye disease and ocular neuropathic pain with Chemerin or a fragment of analog thereof and a lipid entity linked to the Chemerin’

Chemarin project the BAM-8 peptide IP is Big As proved by recent medial research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036347/

http://www.pnas.org/content/by/volume/1

AIQ did 7p to 150p, OKYO only did 2p to 4p, let it do 10 bagger and I will sell while you keep watching us make money.
Most importantly, nobody buys or sells listening to others apart from fools

Don’t tell me when to sell, who gave you this right? It’s my money, I decide if i should sell, keep or through it in the bin, don’t give me financial advice

I saw you are a holder in AIQ, what price did you pay there 150p? Lol, many were comparing OKYO with AIQ, I think you are having a go at us as you are about to miss another AIQ type rise and buy on top maybe, with your knowledge you will end up buying at 20p plus